UPDATE: Helus Pharma (HELP) - Cola Gets the Boot, Trump Signs the EO, Millennium Doubles Down

The Big Pharma Makeover Loses Its Architect — But the Stock Rips +24% Anyway

A month ago I told you Izzy Englander was buying the dip while retail panicked over the pooled data trick. Since then the stock has ripped from $4.52 to $5.61 (+24.1%) on a stack of news that, frankly, I did not see coming in this combination: the Board fired CEO Michael Cola on April 20, the White House dropped a psychedelic-friendly Executive Order the same day, and Millennium quietly upsized its stake from 4.8% to 5.7%. The thesis has not broken, but the architect of the Big Pharma Makeover is gone, and that deserves a hard look.